Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 20;59(10):e0127821.
doi: 10.1128/JCM.01278-21. Epub 2021 Jul 28.

Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System

Douglas Blackall  1 , Raymond Moreno  1 , Justin Jin  1 , Rachel Plotinsky  1 , Ronald Dworkin  1 , Margret Oethinger  1
Affiliations

Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System

Douglas Blackall et al. J Clin Microbiol. .
No abstract available

Keywords: COVID-19; PCR; SARS-CoV-2; coronavirus.

PubMed Disclaimer

References

    1. US Food and Drug Administration. 2021. Potential for false results with Roche Molecular Systems, Inc. cobas SARS-CoV-2 & Influenza Test for use on cobas Liat System-letter to clinical laboratory staff, point-of-care facility staff, and health care providers. https://www.fda.gov/medical-devices/letters-health-care-providers/potent....
    1. Hansen G, Marino J, Wang Z-X, Beavis KG, Rodrigo J, Labog K, Westblade LF, Jin R, Love N, Ding K, Garg S, Huang A, Sickler J, Tran NK. 2021. Clinical performance of the point-of-care cobas Liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study. J Clin Microbiol 59:e02811-20. doi:10.1128/JCM.02811-20. - DOI - PMC - PubMed
    1. Roche Diagnostics Corporation. 2021. cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization-potential for invalid or false positive results. Roche Diagnostics Corporation, Indianapolis, IN.
    1. US Food and Drug Administration. 2020. Emergency use authorization. https://www.fda.gov/media/142190/download.